In a report released on September 20, Jakob Cakarnis from Jarden maintained a Buy rating on ALS Ltd. (CPBLF – Research Report), with a ...

Columnist Juliet Taylor reflects on how the power of music helped her and her late husband, Jeff, navigate the difficulties ...

People living with ALS, family members, friends, caregivers and anyone affected by the disease will come together for the ...

ALS New Mexico held its 24th annual Walk to End Alzheimer’s at UNM’s Track and Soccer Complex near University and Avenida ...

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...

Wendel died months before the ice bucket challenge went viral. Her husband recounts the journey. ALS walk on Sept. 28 honors ...

Goldman Sachs analyst Niraj Shah maintained a Buy rating on ALS Ltd. (CPBLF – Research Report) today. The company’s shares closed ...

If you or a loved one is diagnosed with ALS, you may go through a range of emotions. Remember, there’s no right way to feel about this disease. Give yourself time to let the news settle in.

In the last year alone, the U.S. Food and Drug Administration approved two new treatments for ALS, both developed with funds from the challenge. Today, researchers are considered closer than ever ...

MediciNova, Inc. (NASDAQ:MNOV) is currently evaluating MN-166 (ibudilast) in a Phase 3 clinical trial for amyotrophic lateral sclerosis (ALS). The trial initiated in 2019 and, if successful ...

Cumulative evidence suggests that sporadic ALS may result from complex interactions between genetic susceptibility and aging. Subscribe to Technology Networks’ daily newsletter, delivering breaking ...